Thiopurinemethyltransferase (TPMT) genotype and TPMT activity in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: relation to azathioprine maintenance treatment and adverse effects.
P M
PM
Stassen
R P H
RP
Derks
C G M
CG
Kallenberg
C A
CA
Stegeman
D019268:Antibodies, Antineutrophil Cytoplasmic / Q000032:analysis*; D001379:Azathioprine / Q000627:therapeutic use*; D005838:Genotype; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008780:Methyltransferases / Q000235:genetics*; D012189:Retrospective Studies; D016896:Treatment Outcome; D014657:Vasculitis / Q000235:genetics*
D019268:Antibodies, Antineutrophil Cytoplasmic; D007166:Immunosuppressive Agents; D008780:Methyltransferases; C022745:thiopurine methyltransferase; D001379:Azathioprine